Back to Search
Start Over
Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Chronic Liver Disease
- Source :
- Medicine; July 2023, Vol. 3 Issue: 3 p120-126, 7p
- Publication Year :
- 2023
-
Abstract
- Patients with chronic liver diseases (CLDs) have high hospitalization and mortality rates when combined with severe coronavirus disease 2019 (COVID-19) because of defects in humoral and cellular immunity, known as immune dysfunction. COVID-19 vaccines effectively reduce the risk of severe illness and mortality caused by the virus. Several studies have confirmed the safety and efficacy of the COVID-19 vaccine in patients with CLD, and the existing expert consensus recommends that patients with stable CLD be prioritized for the COVID-19 vaccine. In addition, clinical trials are ongoing to determine the optimal strategy for patients with CLD to receive the COVID-19 vaccine. In this study, we review the progress of research on the safety and efficacy of COVID-19 vaccination in patients with CLD, aiming to provide better recommendations for the vaccination in this population.
Details
- Language :
- English
- ISSN :
- 00257974 and 15365964
- Volume :
- 3
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs63627583
- Full Text :
- https://doi.org/10.1097/ID9.0000000000000094